Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning

NCT05257694 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2022-10-21

No results posted yet for this study

Summary

Developing a deep learning model based on contrast-enhanced ultrasound (CEUS) to predict the prognosis of hepatocellular carcinoma (HCC) and aid choose operation decisions

Conditions

Interventions

PROCEDURE

Surgery

hepatectomy

PROCEDURE

Ablation (Microwave ablation or Radiofrequency ablation)

image-guided ablation

Sponsors & Collaborators

  • Ping Liang

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05257694 on ClinicalTrials.gov